Archive of the Faculty of Medicine in Bochum
Here you can find older news and press releases from the Faculty of Medicine at Ruhr University Bochum.
For more recent press releases, please take a look at our news.
Do you have questions about our faculty or would you like to report on us? Here you can find our press contact.
Muscle Organoids Offer New Insights into Muscle Diseases
Researchers in Bochum are developing muscle organoids that closely mimic human muscle tissue. This approach opens new ways to study diseases and test therapies more precisely, marking an important step toward personalized medicine.
Hepatitis E Viruses Evolve Early During Infection
Researchers show that hepatitis E viruses undergo genetic changes early in infection. These adaptations may affect how the virus spreads in the body and evades the immune system, offering important clues for developing new therapies.
Apple Tree Honors Ulf Eysel for 100 Semesters Teaching
After 100 semesters of dedicated teaching, Ulf Eysel is honored with an apple tree at Ruhr University Bochum. Colleagues celebrate his long-standing commitment to education in the field of neuroscience.
Psychiatrist Theo Payk shaped Bochum Model in Medicine
Prof. Dr. Theo R. Payk established the psychiatric university clinic in Bochum and integrated the discipline into the medical faculty. With the “Bochum model,” he closely linked patient care, research, and teaching, leaving a lasting impact.
More Study Slaces with Expanded Rural Doctor Quota
North Rhine-Westphalia is increasing the rural doctor quota, creating additional study places. Those committing early to general practice can secure admission and agree to work later in underserved rural areas.
Alzheimer Biomarker P-tau217 shows Early Limitations
The biomarker p-tau217 is considered promising for early Alzheimer’s detection but shows surprisingly weak performance in preclinical stages. The study led by Prof. Dr. Gerwert challenges current assumptions and may influence the development of future diagnostic approaches.
Melanoma Research Advances Personalized Immunotherapy
A research project led by Dr. Christina Scheel explores how melanoma cells evade the immune system and why immunotherapies fail in some patients. The aim is to develop a test that better predicts treatment response and supports more individualized therapy decisions.
